Project Grant RF1AG090910
Award Date 9/15/25
Completion Date 8/31/29
Dollars Obligated $3.4M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
- The National Institute on Aging (NIA), part of the U.S. Department of Health and Human Services, awarded a $638,682 project grant under the Aging Research Federal Grant Program (CFDA 93.866) to the University of Arizona on August 1, 2025. The project, titled "TDP-43 LLPS and Mitochondrial Dysfunction in Neurodegeneration", aims to investigate the relationship between the liquid-liquid phase separation (LLPS) of the TDP-43 protein and mitochondrial dysfunction in neurodegenerative...
- The National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), awarded a $404,058 project grant to the Regents of the University of Minnesota to support a novel approach to restore functional TDP43 for the treatment of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The goal of the project is to identify small molecule compounds that can stabilize functional, multimerized forms of the TDP43 protein in order to restore its normal RNA...
- The National Institute on Aging (NIA), part of the U.S. Department of Health and Human Services, awarded a $442,750 Project Grant under the Aging Research federal grant program (CFDA 93.866) to Case Western Reserve University (CWRU) on May 15, 2025. The grant supports exploratory research to develop synthetic replicas of TDP-43 filaments associated with frontotemporal dementia, a key histopathological feature of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. The goal is...
- This $2,817,215 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is supporting research to elucidate the role of the TRIM10 protein in maintaining the solubility and function of the TDP-43 protein. TDP-43 misfolds and aggregates in progressive neurodegenerative diseases like amyotrophic lateral sclerosis (ALS) and frontotemporal...
- This $816,661 Project Grant award, issued on June 1, 2025 by the National Institute on Aging (CFDA 93.866 Aging Research program), supports comprehensive research aimed at elucidating the molecular mechanisms underlying tauopathies such as Alzheimer's disease and frontotemporal dementia. The project, titled "Aberrant Proteomes in Tauopathy: Revealing Functional Consequences via Multimodal Proteomics", combines expertise in mass spectrometry-based proteomics and functional genomics to...
- This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $2,709,695 in funding to The Trustees of the University of Pennsylvania to conduct research on the role of TRIM11 in regulating the proteins TDP-43 and FUS. The research aims to determine how TRIM11 maintains the functional, soluble state of these proteins and if its...
- This $3,081,936 federal Project Grant award was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award supports research at the University of California, San Diego (UCSD) to investigate the mechanisms underlying TDP-43 proteinopathies, which are associated with amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), Alzheimer's disease,...
- This $146,922 Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) supports research to investigate physiological pathways that modulate the regulation of the tau protein, which is associated with neurodegenerative diseases like Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS). The research is being conducted by the Johns Hopkins University and aims to better understand how disruptions in the signaling pathway involving the enzyme GDE2 lead to...
- The National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), awarded a $805,573 project grant to The Regents of the University of California, San Francisco to investigate the impact of m6A RNA modifications in Alzheimer's disease and related tauopathies. The grant will support research to uncover changes in m6A RNA modifications and their functional consequences in post-mortem brain tissue from subjects with Alzheimer's disease and other tauopathies,...
- This Project Grant award from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), provides $848,993.00 to examine tRNA modifications in Alzheimer's disease and related dementias (ADRD). The research aims to investigate how changes in the tRNA epitranscriptome and tRNA translation dynamics contribute to protein misfolding and proteotoxic stress in ADRD. The project will run from September 15, 2025 to May 31, 2030 and is being conducted by the...